GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovis AB (OSTO:GENO) » Definitions » Float Percentage Of Total Shares Outstanding

Genovis AB (OSTO:GENO) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 05, 2025)


View and export this data going back to 2005. Start your Free Trial

What is Genovis AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Genovis AB's float shares is 0.00 Mil. Genovis AB's total shares outstanding is 65.47 Mil. Genovis AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Genovis AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Genovis AB's Institutional Ownership is 28.82%.


Genovis AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Genovis AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/65.47
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genovis AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovis AB (OSTO:GENO) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
Address
Scheelevagen 2, Box 790, Lund, SWE, SE-220 07
Genovis AB provides enzymes and technologies for the analytical characterization and conjugation of biopharmaceuticals. The principal activities of the company are to develop, produce, and market tools for developing new drugs and diagnostics. Its product line comprises GingisREX, FabRICATOR, GlyCLICK, GingisKHAN, GlycINATOR, Fabulous, lgGZERO, and Enzymes for O-glycan. The company's main product category consists of Enzymes and Antibodies. Geographically its segments include Sweden and the rest of the world.

Genovis AB Headlines

No Headlines